Your browser doesn't support javascript.
loading
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
Foster, Jessica B; Griffin, Crystal; Rokita, Jo Lynne; Stern, Allison; Brimley, Cameron; Rathi, Komal; Lane, Maria V; Buongervino, Samantha N; Smith, Tiffany; Madsen, Peter J; Martinez, Daniel; Delaidelli, Alberto; Sorensen, Poul H; Wechsler-Reya, Robert J; Karikó, Katalin; Storm, Phillip B; Barrett, David M; Resnick, Adam C; Maris, John M; Bosse, Kristopher R.
Afiliación
  • Foster JB; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA fosterjb@chop.edu.
  • Griffin C; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Rokita JL; Center for Data-Driven Discovery in Biomedicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Stern A; Center for Data-Driven Discovery in Biomedicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Brimley C; Center for Data-Driven Discovery in Biomedicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Rathi K; Department of Bioinformatics and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Lane MV; Division of Neurosurgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Buongervino SN; Center for Data-Driven Discovery in Biomedicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Smith T; Division of Neurosurgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Madsen PJ; Center for Data-Driven Discovery in Biomedicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Martinez D; Department of Bioinformatics and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Delaidelli A; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Sorensen PH; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Wechsler-Reya RJ; Center for Data-Driven Discovery in Biomedicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Karikó K; Center for Data-Driven Discovery in Biomedicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Storm PB; Division of Neurosurgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Barrett DM; Department of Pathology & Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Resnick AC; Department of Pathology & Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Maris JM; Department of Pathology & Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Bosse KR; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
J Immunother Cancer ; 10(9)2022 09.
Article en En | MEDLINE | ID: mdl-36167467

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias Cerebelosas / Anticuerpos de Cadena Única / Receptores Quiméricos de Antígenos / Glioma / Meduloblastoma / Neuroblastoma Tipo de estudio: Prognostic_studies Límite: Child / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias Cerebelosas / Anticuerpos de Cadena Única / Receptores Quiméricos de Antígenos / Glioma / Meduloblastoma / Neuroblastoma Tipo de estudio: Prognostic_studies Límite: Child / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos